The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.

Atalay G., Dirix L., Biganzoli L., Beex L., Nooij M., Cameron D., ...Daha Fazla

Annals of oncology : official journal of the European Society for Medical Oncology, cilt.15, ss.211-7, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1093/annonc/mdh064
  • Dergi Adı: Annals of oncology : official journal of the European Society for Medical Oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.211-7
  • Anahtar Kelimeler: breast cancer, exemestane, lipid profile, AROMATASE INHIBITOR, ANASTROZOLE, THERAPY, LETROZOLE, METABOLISM, SUPERIOR, RISK, BONE
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır